Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

FDA to Meet to Review Genentech Drug For New Use

By Pharmaceutical Processing | March 10, 2009

WASHINGTON (AP) — The Food and Drug Administration will meet later this month to review Genentech’s blockbuster cancer drug Avastin for a new use against a form of brain cancer. The agency’s panel of outside cancer experts will meet March 31 to assess the safety and effectiveness of the injectable drug for patients with glioblastoma multiforme, the deadliest type of brain tumor. The FDA is not required to follow the advice of its panelists, though it usually does. Avastin is already approved to treat colon and breast cancer, along with the most common form of lung cancer. The drug was Genentech’s top-selling product last year with sales of $2.69 billion in U.S. revenue. South San Francisco, Calif.-based Genentech has asked the FDA to approve its application under the accelerated approval program, which grants market access to drugs with promising preliminary results. Companies gain full approval after submitting follow-up studies that confirm their drugs’ effectiveness. Roughly 10,000 U.S. patients are affected each year by glioblastoma multiforme, according to the National Cancer Institute. The cancer quickly returns in nearly all patients treated for the disease.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards